Tissue Plasminogen Activator, von Willebrand Factor, and Risk of Type 2 Diabetes in Older Men
- 1 May 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (5) , 995-1000
Abstract
OBJECTIVE—The objective of this study was to assess the relationship between putative markers of endothelial dysfunction (tissue plasminogen activator [t-PA] antigen and von Willebrand factor [vWF] antigen) and development of type 2 diabetes, as well as the role of inflammation, adipokines, hepatic function, and insulin resistance in modifying these relationships. RESEARCH DESIGN AND METHODS—This was a prospective study of 3,562 nondiabetic men aged 60–79 years followed up for an average of 7 years during which there were 162 incident cases of type 2 diabetes. RESULTS—Elevated t-PA (top third) was associated with a near threefold increase in risk of diabetes compared with the risk in those in the bottom third after adjustment for lifestyle factors and waist circumference (relative risk [RR] 2.98 [95%CI 1.79–5.00]; Ptrend < 0.0001); weaker but significant (marginal) associations were seen with vWF (1.24 [0.83–1.85]; P = 0.05 for trend). Both biomarkers of endothelial dysfunction correlated significantly with markers of inflammation (interleukin-6 [IL-6] and C-reactive protein [CRP]), hepatic function (γ-glutamyl transferase [GGT]), and insulin resistance, with t-PA showing stronger associations with adiposity, hepatic function, and insulin resistance than vWF. t-PA was also significantly and inversely associated with adiponectin. Adjustment for IL-6, adiponectin, and GGT attenuated the association of incident diabetes with vWF (1.06 [0.71–1.60]), but the relationship seen with t-PA remained significant (adjusted RR 2.19 [1.29–3.70]). Subsequent adjustment for insulin attenuated the association further, but t-PA was still associated with a significant increase in risk (1.66 [0.96–2.85]; Ptrend = 0.02). CONCLUSION—t-PA antigen, but not vWF antigen, is independently associated with risk of type 2 diabetes.Keywords
This publication has 34 references indexed in Scilit:
- Circulating Levels of Endothelial Adhesion Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of WomenDiabetes, 2007
- Adipokines and Risk of Type 2 Diabetes in Older MenDiabetes Care, 2007
- Progression of Plasminogen Activator Inhibitor-1 and Fibrinogen Levels in Relation to Incident Type 2 DiabetesCirculation, 2006
- Endothelial inflammation in insulin resistanceThe Lancet, 2005
- Endothelial inflammation in insulin resistanceThe Lancet, 2005
- Tissue plasminogen activator antigen and coronary heart disease Prospective study and meta-analysisEuropean Heart Journal, 2004
- A Specific Elevation in Tissue Plasminogen Activator Antigen in Women with Polycystic Ovarian SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2002
- Hemostatic and Rheological Variables and Risk of Cardiovascular DiseaseSeminars in Vascular Medicine, 2002
- Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.Journal of Clinical Pathology, 1994
- British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.BMJ, 1981